OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • In-person and virtual events just for HCPs
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe
Advertisement

Update on Systemic Therapy for Advanced Liver Cancer

home / news-network / update-on-systemic-therapy-for-advanced-liver-cancer
Newly Diagnosed Advanced HCC: Frontline Therapy Overview

EP. 1: Newly Diagnosed Advanced HCC: Frontline Therapy Overview

December 2nd 2019
Selecting a Frontline TKI for Advanced HCC

EP. 2: Selecting a Frontline TKI for Advanced HCC

December 2nd 2019
Frontline I/O Therapy for HCC: Results From CheckMate459

EP. 3: Frontline I/O Therapy for HCC: Results From CheckMate459

December 2nd 2019
Advanced HCC: Trial Data for Frontline Combination Therapy

EP. 4: Advanced HCC: Trial Data for Frontline Combination Therapy

December 2nd 2019
Future of Frontline Combination Therapy in Advanced HCC

EP. 5: Future of Frontline Combination Therapy in Advanced HCC

December 2nd 2019
Second-Line Therapy for Advanced HCC: The RESOURCE Trial

EP. 6: Second-Line Therapy for Advanced HCC: The RESOURCE Trial

December 2nd 2019
Second-Line Therapy for Advanced HCC: The CELESTIAL Trial

EP. 7: Second-Line Therapy for Advanced HCC: The CELESTIAL Trial

December 2nd 2019
Second-Line Use of I/O Therapy for Advanced HCC

EP. 8: Second-Line Use of I/O Therapy for Advanced HCC

December 2nd 2019
Advanced HCC: Guiding Second-Line Therapy With AFP

EP. 9: Advanced HCC: Guiding Second-Line Therapy With AFP

December 2nd 2019
Evolving HCC Treatment Paradigm: Combinations and Sequencing

EP. 10: Evolving HCC Treatment Paradigm: Combinations and Sequencing

December 2nd 2019

Latest Conference Coverage

Dr Van Gorp on the Long-Term Efficacy of Mirvetuximab Soravtansine in FRα+ Platinum-Resistant Ovarian Cancer

Zimberelimab Plus Lenvatinib Shows Activity in ICI-Pretreated Advanced Cervical Cancer

Afuresertib Plus Paclitaxel Does Not Elicit Substantial Clinical Benefit in Platinum-Resistant Ovarian Cancer

Olaparib After Durvalumab/Chemo Boosts PFS in Subgroups of pMMR Endometrial Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact